188 related articles for article (PubMed ID: 38481996)
1. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
Liu T; Zhao H; Wang Y; Qu P; Wang Y; Wu X; Zhao T; Yang L; Mao H; Peng L; Zhan Y; Li P
Front Immunol; 2024; 15():1334109. PubMed ID: 38481996
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
Xu X; Dong Y; Liu M; Li Y; Zhang Y
Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
4. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
5. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
6. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
7. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
[TBL] [Abstract][Full Text] [Related]
8. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
[TBL] [Abstract][Full Text] [Related]
9. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L
Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561
[TBL] [Abstract][Full Text] [Related]
10. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
[TBL] [Abstract][Full Text] [Related]
12. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
13. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
14. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
[TBL] [Abstract][Full Text] [Related]
15. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline.
Xu J; Jin L; Sun Y; Zhang R; Chen X; Zhou R; Gu Y; Hu C
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3554. PubMed ID: 35667014
[TBL] [Abstract][Full Text] [Related]
16. Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease.
Lin Z; Zhang D; Zhang X; Guo W; Wang W; Zhang Y; Liu Z; Bi Y; Wu M; Lin Z; Lu X
BMC Nephrol; 2023 May; 24(1):154. PubMed ID: 37259071
[TBL] [Abstract][Full Text] [Related]
17. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
18. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
[TBL] [Abstract][Full Text] [Related]
19. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
Zhou Y; Ren J; Li P; Ma R; Zhou M; Zhang N; Kong X; Hu Z; Xiao X
Arch Med Res; 2019 Jul; 50(5):249-256. PubMed ID: 31593848
[TBL] [Abstract][Full Text] [Related]
20. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
